{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T04:20:51Z","timestamp":1692764451248},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7791","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T22:18:31Z","timestamp":1490998711000},"page":"861-864","source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Biphasic Malignant Peritoneal Mesothelioma with Refractory Ascites"],"prefix":"10.2169","volume":"56","author":[{"given":"Tomo","family":"Komaki","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukuoka University Chikushi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Urata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukuoka University Chikushi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukuoka University Chikushi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Iwashita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fukuoka University Chikushi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fukuoka University Chikushi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Haraoka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fukuoka University Chikushi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sugarbaker PH, Welch LS, Mohamed F, Glehen O. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 12: 605-621, 2003.","DOI":"10.1016\/S1055-3207(03)00045-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wang J, Gao L, Tang S, et al. A retrospective analysis on the diagnostic value of ultrasound-guided percutaneous biopsy for peritoneal lesions. World J Surg Oncol 11: 251, 2013.","DOI":"10.1186\/1477-7819-11-251"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kebapci M, Vardareli E, Adapinar B, Acikalin M. CT findings and serum CA 125 levels in malignant peritoneal mesothelioma: report of 11 new cases and review of the literature. Eur Radiol 13: 2620-2626, 2003.","DOI":"10.1007\/s00330-003-1851-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Baratti D, Kusamura S, Martinetti A, et al. Circulating CA125 in patients with peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 14: 500-508, 2007.","DOI":"10.1245\/s10434-006-9192-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takeshima Y, Amatya VJ, Kushitani K, Inai K. A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases. Am J Clin Pathol 130: 771-779, 2008.","DOI":"10.1309\/AJCPHSUJ15NEYMIP"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Comin CE, Saieva C, Messerini L. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol 31: 1139-1148, 2007.","DOI":"10.1097\/PAS.0b013e318033e7a8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lyons-Boudreaux V, Mody DR, Zhai J, Coffey D. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology? Arch Pathol Lab Med 132: 23-28, 2008.","DOI":"10.5858\/2008-132-23-CMVBHU"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Onofre FB, Onofre AS, Pomjanski N, Buckstegge B, Grote HJ, B\u00f6cking A. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis. Cancer 114: 204-215, 2008.","DOI":"10.1002\/cncr.23413"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Selleslag DL, Geraghty RJ, Ganesan TS, Slevin ML, Wrigley PF, Brown R. Autoimmune haemolytic anaemia associated with malignant peritoneal mesothelioma. Acta Clin Belg 44: 199-201, 1989.","DOI":"10.1080\/17843286.1989.11718015"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/7\/56_56.7791\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T23:34:05Z","timestamp":1692747245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/7\/56_56.7791\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7791","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}